Glucose in the cerebrospinal fluid (CSF) of neonates, as measured with a kinetic glucose oxidase/peroxidase procedure, was sometimes very low. When these samples were stored at 4 #{176}C and subsequently re-analyzed, or if the samples were analyzed at any time after receipt by using a glucose dehydrogenase assay, the values were much higher. We found that the discrepancies in the values were caused by a lag phase in the kinetic method, during which no color developed. Because the lag phase exceeds the time over which the reaction is monitored in the kinetic procedure, this leads to the erroneously low values. The interference could be reproduced experimentally by adding ascorbic acid to CSF or plasma samples, or removed by adding ascorbate oxidase to CSF samples. Plasma glucose, as estimated by the kinetic glucose oxidase method, showed no such interference.
enzymic methods diagnosis of meningitis

Measurement of glucose in cerebrospinal fluid (CSF) is
important in the differential diagnosis of meningitis. Low values are found in bacterial meningitis, whereas in viral meningitis the CSF glucose concentration is normal (1). An erroneously low value could therefore lead to unnecessary antibiotic therapy, which carries its own potential dangers (2). Here we present evidence that ascorbic acid in CSF can interfere in the determination of glucose by a kinetic glucose oxidase/peroxidase method and may lead to erroneously low results.
Materials and Methods
Reagents
Glucose oxidase reagent (glucose reagent 919, cat. no.
97532) was obtained from Instrumentation Laboratory (UK)
Ltd., Warrington, 
U.K. Glucose dehydrogenase (EC 1.4.1.2) reagent (Mercotest glucose
Gluc
Results
Incidence of discrepant results. During a three-month period, 10 of 24 samples of CSF collected from premature and full-term neonates, when analyzed by the kinetic glucose oxidase/peroxidase procedure, were found to have a low glucose content (<2.0 mmoli'L). In eight of these, the results from the end-point glucose dehydrogenase method were much higher than those from the kinetic glucose oxidase method (Table 1) . We concluded that these differences were caused by a labile interference in the kinetic glucose oxidase/peroxidase procedure, because samples that were left overnight at 4#{176}C and subsequently re-assayed gave results identical to those obtained by the end-point glucose dehydrogenase method.
Effects of potential interferents
on reaction kinetics. The effects of several substances that might be found in the CSF Table 1 analyzer to facilitate studies of the reaction kinetics. In the CSF samples with apparently low glucose concentrations, there was a delay in the development of color. However, if the samples were allowed to age, this "lag phase" was reduced (Figure la) .
That the presence of ascorbate in CSF caused the interference was confirmed by adding ascorbate oxidase to several samples; this removed the lag phase from the subsequent glucose oxidase/peroxidase reaction (Figure lb) . Moreover, the addition of ascorbic acid to CSF produced a lag phase and interference in the laboratory method identical to that observed in the patients' samples.
If the end-point glucose oxidase method was used to determine glucose concentrations, the results obtained were slightly lower than those obtained by the glucose dehydrogenase method. Similarly, the concentration calculatedfrom the reaction rate immediately after the lag phase were slightly lower. Characteristics of the interference by ascorbate. The characteristics of the interference by ascorbic acid in the glucose oxidase/peroxidase method were investigated. Alteration of the sample size, which would alter the ascorbate concentration in the same proportion as the glucose concentration, had no effect on the lag phase (Figure 2a) . Rather, the lag phase was proportional to the ascorbic acid concentration (Figure 2b) , and inversely proportional to the glucose concentration (Figure 2c) 
Discussion
Early end-point glucose oxidase/peroxidase methods have been shown to be prone to interference from certain drugs (5); moreover, it has been shown that ascorbic acid interferes with reactions that generate hydrogen peroxide (6). However, there is disagreement in the literature as to the extent of interference by ascorbate in end-point glucose oxidase/peroxidase methods. Lott and Turner (7) found that 2.8 mmol/L ascorbate decreased the apparent glucose from 7.2 mmol/L to 0. This would indicate that each molecule of ascorbate was capable of reacting with the H202 produced by 2.6 molecules of glucose. Gochman and Schmitz (8) found that 0.57 mmol/L ascorbate decreased the apparent glucose concentration by about 0.2 mmolJL. Pennock et al. (9) reported that 5.7 mmol/L had no effect. The disagreement in the literature may in part be due to the lability of the interference. Our results indicate that ascorbate would decrease the apparent concentration in an end-point glucose oxidase/ peroxidase method, molecule for molecule. This may indicate a much higher affinity of ascorbate for peroxidase relative to the affinity of 4-aininophenazone for peroxidase. The fact that increasing the concentration of 4-aminophena-zone as much as 100-fold does not remove the interference supports this supposition.
The form of the interferenceis such that there is a lag phase during which no color develops. This lag phase is directly proportional to the concentration of ascorbate and inverselyproportional to the glucose oxidase concentration in the reagent. Clearly, the degree of interference in the glucose measurement will depend upon the constitution of the reagent and the time course over which the reaction is monitored, with the greatest interference being where the reaction is monitored shortly after mixing and over a short interval of time. Thus, kinetic methods are potentially more susceptible to interference of this type.
The interference would appear to be due to preferential oxidation of the ascorbic acid. There appears to be no way in which this can be overcome without resorting to pre-incubation of each sample with ascorbate oxidase, because other alterations of the reaction conditions did not overcome the interference. One solution to this problem would be to use an end-point glucose oxidase/peroxidase method in which minimal interference is observed or to use a method based on the use of glucose dehydrogenase. Because the glucose dehydrogenase method does not appear to suffer from this interference, it therefore can be used with confidence in a formulation that meets the needs of the instrumentation available.
The interference of ascorbate in glucose measurements was confined solely to neonatal CSF samples. No interference was observed in any neonatal blood samples, adult CSF samples, or adult blood samples taken after an ascorbic acid load. The lack of interference in blood samples is explained by ascorbate being at a higher concentration in CSF than in
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CHEM. 29/10, 181 2-1 814 (1983) plasma (10,11). No CSF samples were obtained from adults known to have taken ascorbate; it is likely, however, that such samples would demonstrate the interference.
